ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 1,013 filers reported holding ASTRAZENECA PLC in Q2 2022. The put-call ratio across all filers is 1.36 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,108,419 | +15.4% | 14,212 | +0.3% | 0.03% | +8.3% |
| Q1 2024 | $960,246 | +103.4% | 14,173 | +102.2% | 0.02% | +71.4% |
| Q4 2023 | $472,115 | +10.7% | 7,010 | +11.3% | 0.01% | -6.7% |
| Q3 2023 | $426,560 | +15.8% | 6,299 | +22.4% | 0.02% | +7.1% |
| Q2 2023 | $368,381 | +1.0% | 5,147 | -2.1% | 0.01% | -6.7% |
| Q1 2023 | $364,829 | +0.9% | 5,256 | -1.4% | 0.02% | -6.2% |
| Q4 2022 | $361,573 | +17.8% | 5,333 | -4.6% | 0.02% | +6.7% |
| Q3 2022 | $307,000 | -9.2% | 5,591 | +9.3% | 0.02% | -6.2% |
| Q2 2022 | $338,000 | -9.8% | 5,114 | -9.4% | 0.02% | 0.0% |
| Q1 2022 | $374,601 | -8.2% | 5,647 | -19.4% | 0.02% | -5.9% |
| Q4 2021 | $408,000 | -5.3% | 7,004 | -2.3% | 0.02% | -15.0% |
| Q3 2021 | $431,000 | +2.1% | 7,168 | +2.5% | 0.02% | -4.8% |
| Q2 2021 | $422,000 | +22.7% | 6,992 | +0.6% | 0.02% | +5.0% |
| Q1 2021 | $344,000 | -10.4% | 6,950 | -9.5% | 0.02% | -28.6% |
| Q4 2020 | $384,000 | +16.7% | 7,682 | +27.8% | 0.03% | -3.4% |
| Q3 2020 | $329,000 | +31.6% | 6,013 | +27.4% | 0.03% | +16.0% |
| Q2 2020 | $250,000 | +18.5% | 4,718 | +11.5% | 0.02% | -3.8% |
| Q4 2019 | $211,000 | – | 4,230 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| STARR INTERNATIONAL CO INC | 93,000 | $5,586,000 | 11.21% |
| Eagle Health Investments LP | 449,565 | $27,001,000 | 8.56% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,291,667 | $77,578,000 | 6.52% |
| Healthcare Value Capital, LLC | 50,000 | $3,003,000 | 5.93% |
| ARDSLEY ADVISORY PARTNERS LP | 500,000 | $30,030,000 | 4.58% |
| Asymmetry Capital Management, L.P. | 116,242 | $6,981,000 | 4.20% |
| Swaine & Leidel Wealth Services, LLC | 75,880 | $4,557,000 | 4.02% |
| Sofinnova Investments, Inc. | 1,128,272 | $67,764,000 | 4.01% |
| Eversept Partners, LP | 890,808 | $53,501,928 | 3.71% |
| Ruffer LLP | 1,971,796 | $117,064,000 | 3.70% |